Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 104145-95-1
Drug Levels and Effects
Summary of Use during Lactation
Cefditoren is no longer marketed in the United States. Because of the low levels of cefditoren in breastmilk, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush, have been reported with cephalosporins, but these effects have not been adequately evaluated. Cefditoren is acceptable in nursing mothers.
Drug Levels
Maternal Levels. Twelve lactating women were given cefditoren 200 mg before a meal. Complete milk samples were collected with a breast pump 1 hour before administration and at 1, 2, 3, 4, 6, 8, and 12 hours after the dose. The average peak milk level was 11.3 mcg/L, at an average of 4.87 hours after the dose and the half-life in milk was 2.42 hours. The average milk concentration was 5.65 mcg/L, which resulted in a relative infant dose (RID) of 0.0073% of the weight-adjusted dosage.[1] However, the actual milk volumes were low at an average of 405 mL/day and the infant weights averaged 8.8 kg, resulting in a daily infant milk intake of only 45 mL/kg. Using the standard daily milk volume of 150 mL/kg, the RID would be 0.025%. Furthermore, the trough concentration at 12 hours after the dose averaged 5.94 mcg/L, which is similar to the average milk level. Therefore, the peak and average milk levels and the RID are likely to be about double these values at steady-state, but still low (RID~0.05%).
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Chen Z, Feng S, Cai L, et al. Pharmacokinetic study of cefditoren pivoxil in breast milk and blood of lactating women. Biopharm Drug Dispos 2025;46:147–54. [PubMed: 40794466]
Substance Identification
Substance Name
Cefditoren
CAS Registry Number
104145-95-1
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Ceftizoxime.[Drugs and Lactation Database (...]Review Ceftizoxime.. Drugs and Lactation Database (LactMed®). 2006
- Review Ceftriaxone.[Drugs and Lactation Database (...]Review Ceftriaxone.. Drugs and Lactation Database (LactMed®). 2006
- Review Cefotaxime.[Drugs and Lactation Database (...]Review Cefotaxime.. Drugs and Lactation Database (LactMed®). 2006
- Review Cefixime.[Drugs and Lactation Database (...]Review Cefixime.. Drugs and Lactation Database (LactMed®). 2006
- Review Ceftibuten.[Drugs and Lactation Database (...]Review Ceftibuten.. Drugs and Lactation Database (LactMed®). 2006
- Cefditoren - Drugs and Lactation Database (LactMed®)Cefditoren - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...